MX9804860A - Complejos polimericos en cascada, procedimiento para su preparacion y medios farmaceuticos que los contienen. - Google Patents

Complejos polimericos en cascada, procedimiento para su preparacion y medios farmaceuticos que los contienen.

Info

Publication number
MX9804860A
MX9804860A MX9804860A MX9804860A MX9804860A MX 9804860 A MX9804860 A MX 9804860A MX 9804860 A MX9804860 A MX 9804860A MX 9804860 A MX9804860 A MX 9804860A MX 9804860 A MX9804860 A MX 9804860A
Authority
MX
Mexico
Prior art keywords
cascade
reproduction
same
independently represent
multiplicity
Prior art date
Application number
MX9804860A
Other languages
English (en)
Inventor
Heribert Schmitt-Willich
Johannes Platzek
Bernd Raduechel
Hanns-Joachim Weinmann
Wolfgang Ebert
Bernd Misselwitz
Andreas Muehler
Thomas Frenzel
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of MX9804860A publication Critical patent/MX9804860A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/12Macromolecular compounds
    • A61K49/124Macromolecular compounds dendrimers, dendrons, hyperbranched compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Los complejos poliméricos en cascada que contienen a) ligandos formadores de complejos de la formula general I (Ver Formula); en la que A representa un nucleo de cascada nitrogenado de la multiplicidad a de la base, X e Y representan independientemente uno de otro un enlace directo o una unidad de reproduccion de cascada de la multiplicidad de reproduccion x o bien y, Z y W representan independientemente uno de otro una unidad de reproduccion de cascada de la multiplicidad de reproduccion z o bien w, K representa el radical de un formador de complejo, a representa los numeros 2 a 12, z, y, z y representan independientemente uno de otro los numeros 1 a 4, con la condicion de que cuando menos dos unidades de reproduccion sean diferentes, de que para el producto de las multiplicidades valga 16 <- a ?? x ?? y ?? z ?? w <- 64 y, de que cuando menos una de las unidades X, Y, Z, W de reproduccion de cascada represente una unidad de reproduccion 1,4,7,10-tetraazaciclododecano o 1,4,8,11-tetraazacilotetradecano. b) cuando menso 16 tones de un elemento de los numeros atomicos 20 a 29, 39, 42, 44 o 57 -83. c) eventualmente cationes de bases orgánicas y/o inorgánicas, aminoácidos y amidas de aminoácidos, así como d) eventualmente grupos aminos terminales acilados, son compuestos valiosos para el diagnostico y la terapia.
MX9804860A 1995-12-22 1998-06-17 Complejos polimericos en cascada, procedimiento para su preparacion y medios farmaceuticos que los contienen. MX9804860A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19549286A DE19549286A1 (de) 1995-12-22 1995-12-22 Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel

Publications (1)

Publication Number Publication Date
MX9804860A true MX9804860A (es) 1998-10-31

Family

ID=7781739

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9804860A MX9804860A (es) 1995-12-22 1998-06-17 Complejos polimericos en cascada, procedimiento para su preparacion y medios farmaceuticos que los contienen.

Country Status (23)

Country Link
US (1) US6057419A (es)
EP (1) EP0868202B1 (es)
JP (1) JP4031041B2 (es)
KR (1) KR100461476B1 (es)
AT (1) ATE222776T1 (es)
BG (1) BG63105B1 (es)
CA (1) CA2241187A1 (es)
CZ (1) CZ294238B6 (es)
DE (2) DE19549286A1 (es)
DK (1) DK0868202T3 (es)
ES (1) ES2181924T3 (es)
IL (1) IL124677A (es)
MX (1) MX9804860A (es)
NO (1) NO314545B1 (es)
NZ (1) NZ323397A (es)
PL (1) PL187835B1 (es)
PT (1) PT868202E (es)
RU (1) RU2197495C2 (es)
SK (1) SK283334B6 (es)
TW (1) TW520377B (es)
UA (1) UA50753C2 (es)
WO (1) WO1997023245A1 (es)
ZA (1) ZA9610822B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19652387A1 (de) * 1996-12-04 1998-06-10 Schering Ag Macrocyclische Metallkomplexcarbonsäuren, ihre Verwendung sowie Verfahren zu ihrer Herstellung
DE19728954C1 (de) * 1997-06-30 1999-04-22 Schering Ag Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19744003B4 (de) * 1997-09-26 2004-07-08 Schering Ag Kontrastmittel für das Infarkt- und Nekroseimaging
DE19758105A1 (de) * 1997-12-18 1999-06-24 Schering Ag Dendritische Polymer-Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung
US7405320B2 (en) * 1998-06-22 2008-07-29 Immunomedics, Inc. Therapeutic and diagnostic conjugates for use with multispecific antibodies
FR2841258A1 (fr) * 2002-06-20 2003-12-26 Pf Medicament Procede et preparation de mononegavirus recombinants et leurs applications
CA2645668A1 (en) 2006-03-14 2007-09-20 Mallinckrodt Inc. Metal complexes of tetraazamacrocycle derivatives
DE102007002726A1 (de) * 2007-01-18 2008-07-31 Bayer Schering Pharma Aktiengesellschaft Neue Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
WO2014197763A1 (en) * 2013-06-07 2014-12-11 The Board Of Regents Of The University Of Teas System Molecular design toward dual-modality probes for radioisotope-based imaging (pet or spect) and mri
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
US10975060B2 (en) 2016-11-28 2021-04-13 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
PE20211471A1 (es) 2018-11-23 2021-08-05 Bayer Ag Formulacion de medios de contraste y proceso para prepararlos
RU2706705C1 (ru) * 2019-03-28 2019-11-20 Федеральное государственное бюджетное учреждение науки Иркутский институт химии им.А.Е.Фаворского Сибирского отделения Российской академии наук Водорастворимые магнитоактивные нанобиокомпозиты флавоноидных комплексов гадолиния на основе природного конъюгата арабиногалактана с биофлавоноидами и способ получения этих нанобиокомпозитов

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527524A (en) * 1986-08-18 1996-06-18 The Dow Chemical Company Dense star polymer conjugates
DE3938992A1 (de) * 1989-11-21 1991-05-23 Schering Ag Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE4344460A1 (de) * 1993-12-22 1995-06-29 Schering Ag Metallkomplexe von dendrimeren Makromolekülen, diese enthaltende diagnostische Mittel sowie Verfahren zur Herstellung der Komplexe und Mittel
GB9404208D0 (en) * 1994-03-04 1994-04-20 Nycomed Salutar Inc Chelants
GB9407812D0 (en) * 1994-04-20 1994-06-15 Nycomed Salutar Inc Compounds
DE4425857A1 (de) * 1994-07-07 1996-01-11 Schering Ag Kaskaden-Polymer-Komplexe, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Mittel
US5919433A (en) * 1996-12-04 1999-07-06 Schering Aktiengesellschaft Macrocyclic metal complex carboxylic acids, their use as well as process for their production

Also Published As

Publication number Publication date
ES2181924T3 (es) 2003-03-01
RU2197495C2 (ru) 2003-01-27
NO314545B1 (no) 2003-04-07
NO982903D0 (no) 1998-06-22
DK0868202T3 (da) 2002-12-09
ZA9610822B (en) 1997-06-27
KR19990076638A (ko) 1999-10-15
BG63105B1 (bg) 2001-04-30
PL327977A1 (en) 1999-01-04
SK283334B6 (sk) 2003-06-03
EP0868202A1 (de) 1998-10-07
JP4031041B2 (ja) 2008-01-09
JP2000510880A (ja) 2000-08-22
SK85498A3 (en) 1998-11-04
TW520377B (en) 2003-02-11
NZ323397A (en) 1999-11-29
WO1997023245A1 (de) 1997-07-03
CZ294238B6 (cs) 2004-11-10
IL124677A0 (en) 1998-12-06
IL124677A (en) 2005-03-20
CZ198198A3 (cs) 1998-09-16
PT868202E (pt) 2003-01-31
PL187835B1 (pl) 2004-10-29
DE19549286A1 (de) 1997-06-26
EP0868202B1 (de) 2002-08-28
ATE222776T1 (de) 2002-09-15
NO982903L (no) 1998-06-22
CA2241187A1 (en) 1997-07-03
UA50753C2 (uk) 2002-11-15
KR100461476B1 (ko) 2005-04-06
US6057419A (en) 2000-05-02
DE59609603D1 (de) 2002-10-02
BG102565A (en) 1999-06-30

Similar Documents

Publication Publication Date Title
MX9800023A (es) Complejos de polimero de cascada, proceso para su produccion y agentes farmaceuticos que contienen tales complejos.
HU9700025D0 (en) Cascade polymere complexes, process for producing them, and pharmaceutical compositions containing them
MX9804860A (es) Complejos polimericos en cascada, procedimiento para su preparacion y medios farmaceuticos que los contienen.
GR3031629T3 (en) Complexe builders bonded to sterwise prepared polymers, their complexes and conjugates, process for their preparation and pharmaceutical agents containing the same.
GR3017586T3 (en) Complex porphyrine compounds substituted in position 13,17 by propionic acid and propionic-acid derivatives, process for their preparation and pharmaceutical compositions containing same.
HUP9603530A3 (en) Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments
GEP20002206B (en) Cryptophycins, Method for its Production, Pharmaceutical Composition on Their basis and Use
ZA961395B (en) Metal complexes suitable for use in diagnosis and therapy
CZ228195A3 (en) Derivatives of hydroxymethylfurazancarboxylic acid, process of their preparation, their use for treating cardiovascular diseases and a pharmaceutical composition containing thereof
GR3021769T3 (en) N-(isoquinolein-5-yl)-sulfonyl azacycloalkanes, their process of preparation and pharmaceutical compositions containing them
CA2176603A1 (en) Novel palladium complexes and methods for using same in the treatment of tumors and psoriasis